和络舒肝胶囊治疗肝炎后肝硬化的临床疗效

Clinical study on cirrhosis treatcd Heluo Shugan Capsule

目的 探讨 43例肝炎后肝硬化患者 ,在综合治疗的基础上 ,加用和络舒肝胶囊的临床疗效及不良反应。方法 85例肝炎后肝硬化患者 ,随机分成治疗组和对照组 ,其中对照组 42例采用综合保肝治疗。治疗组 43例 ,在综合保肝治疗的基础上 ,加用和络舒肝胶囊 5粒 ,tid ,口服 ,3个月为 1个疗程。结果 疗程结束后 ,治疗组在临床症状、体征、肝功能的改善方面均优于对照组 ,治疗组的总有效率为 90 7% ,对照组的总有效率为 5 4 8% ,两者差异有非常显著性 (P <0 0 1) ,2组均未见严重的药物不良反应。结论 在综合保肝治疗基础上 ,加用和络舒肝胶囊治疗肝炎后肝硬化 ,可以提高疗效 ,建议在临床推广使用。

Objective To observe the therapeutic efficacy and side effects of Heluo Shugan Capsule on cirrhosis Methods 85 patients were randomly divided into two groups 43 patients as a treatment group received 5 pills one time,tid,po Heluo Shugan Capsule combination with routine protection liver drugs and 42 patients as a control group by routine protection liver drugs for 3 months Results After completion of therapy,effective rate of was 91 1% in treatment group and 55 0% in that of control group The clinical syndromes and the liver biochemical function of the treatment group and were much better that of control group There is significant dofferance befineen two group( P <0 01) No side effects were observed Conclusion Heluo Shugan Capsule may improve the therapeutic effect in treating crirrhosis It may be commonly wed in clinical